Konstantinos Markou, Sandrine Eimer, Clotilde Perret, Aymeri Huchet, John Goudakos, Dominique Liguoro, Valérie Franco-Vidal, Jean-Philippe Maire, Vincent Darrouzet
OBJECTIVE: Malignant transformation of vestibular schwannoma is considered a rare clinical entity. Radiotherapy, as a treatment option for vestibular schwannoma, is regarded as a potential risk factor for secondary malignancy. Recently, radiotherapy with dose fractionation has been proposed, intended to diminish the risk of radiation-induced neuropathy. CASE PRESENTATION: The aim of the present study is to report the first case, to the best of our knowledge, of malignant transformation of a residual vestibular schwannoma 19 years after fractionated radiotherapy, describing its characteristics with regard to those previously reported in the literature...
January 2012: American Journal of Otolaryngology